MANKIND Mankind Pharma Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: Healthcare · F&O lot size: 250MANKIND lot size: 250 shares per F&O lot for the 3 listed expiries (2026-10-27, 2026-11-23, 2026-12-29). One lot is worth about ₹5.63 lakh at the last underlying price of ₹2,253.20. All F&O lot sizes →
MANKIND Chart daily candles · add any indicator · computed in your browser
Loading chart…
Daily bars from exchange end-of-day data; during market hours today’s bar updates with the latest price. Splits and bonuses are adjusted; demergers show as the real gaps they were. Volume profile is estimated from each day’s range. D marks a bulk or block deal day (green: net buying, red: net selling, purple: matched cross). Charting by TradingView Lightweight Charts.
Live setups screens MANKIND is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about MANKIND
In the last completed session, Mankind Pharma Ltd. closed -0.95% with futures open interest moving +1.2%. That combination — price falling while OI builds — is classified as Short Buildup. Fresh short positions are being added on weakness, which historically prefaces further downside until shorts are forced to cover. The stock's option PCR sits at 0.47, indicating heavy call-side writing — option dealers see resistance overhead. Max-pain strike at ₹2,360 sits 4.7% above the current price, a mild magnet near expiry.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Mankind Pharma Ltd. over the last 30 sessions.
Putting it together, the smart-money picture for Mankind Pharma Ltd. leans cautious into the next session.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot as of 2026-10-19 close · from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
Broker Calls as reported · last 120 days
| Date | Brokerage | Call | Target | Source |
|---|---|---|---|---|
| 2026-08-20 | InCred | Initiate | — | NDTV Profit |
| 2026-08-19 | InCred | Initiate | — | NDTV Profit |
| 2026-08-18 | InCred | Initiate | — | NDTV Profit |
| 2026-08-17 | InCred | Initiate | — | NDTV Profit |
| 2026-08-02 | InCred | Initiate | — | NDTV Profit |
| 2026-08-01 | InCred | Initiate | — | NDTV Profit |
| 2026-07-30 | InCred | Initiate | — | NDTV Profit |
| 2026-07-29 | InCred | Initiate | — | NDTV Profit |
| 2026-07-28 | InCred | Initiate | — | NDTV Profit |
| 2026-07-27 | InCred | Initiate | — | NDTV Profit |
| 2026-07-26 | InCred | Initiate | — | NDTV Profit |
| 2026-07-25 | InCred | Initiate | — | NDTV Profit |
Insider & Promoter Filings last 60 days
MANKIND Option Chain nearest expiry 2026-10-27 · spot 2,253 · EOD 2026-10-19
MANKIND option chain today (2026-10-27 expiry, NSE data of 2026-10-19): put-call ratio 0.47 · max pain ₹2,360 · highest call OI at ₹2,600 · highest put OI at ₹2,300 · underlying ₹2,253.20. One lot is 250 shares. At-the-money implied volatility 34.6%, IV rank 50 and IV percentile 90 over the past year (range 17.9%–51.3%); 20-day historical volatility 31.8%.
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 43%
Δ 0.95
θ -1.4
ν 0
|
2060 |
IV 43%
Δ -0.05
θ -1.0
ν 0
|
|
IV 39%
Δ 0.94
θ -1.3
ν 0
|
2080 |
IV 39%
Δ -0.06
θ -1.0
ν 0
|
|
IV 41%
Δ 0.91
θ -1.9
ν 1
|
2100 |
IV 41%
Δ -0.09
θ -1.5
ν 1
|
|
IV 40%
Δ 0.88
θ -2.1
ν 1
|
2120 |
IV 40%
Δ -0.12
θ -1.7
ν 1
|
|
IV 39%
Δ 0.85
θ -2.3
ν 1
|
2140 |
IV 39%
Δ -0.15
θ -1.9
ν 1
|
|
IV 38%
Δ 0.81
θ -2.6
ν 1
|
2160 |
IV 38%
Δ -0.19
θ -2.2
ν 1
|
|
IV 37%
Δ 0.77
θ -2.8
ν 1
|
2180 |
IV 37%
Δ -0.23
θ -2.5
ν 1
|
|
IV 38%
Δ 0.71
θ -3.2
ν 1
|
2200 |
IV 38%
Δ -0.29
θ -2.8
ν 1
|
|
IV 37%
Δ 0.65
θ -3.3
ν 1
|
2220 |
IV 37%
Δ -0.35
θ -2.9
ν 1
|
|
IV 38%
Δ 0.59
θ -3.5
ν 1
|
2240 |
IV 38%
Δ -0.41
θ -3.1
ν 1
|
|
IV 37%
Δ 0.52
θ -3.5
ν 1
|
2260 |
IV 37%
Δ -0.48
θ -3.1
ν 1
|
|
IV 37%
Δ 0.45
θ -3.4
ν 1
|
2280 |
IV 37%
Δ -0.55
θ -3.0
ν 1
|
|
IV 37%
Δ 0.38
θ -3.3
ν 1
|
2300 S |
IV 37%
Δ -0.62
θ -2.9
ν 1
|
|
IV 37%
Δ 0.32
θ -3.1
ν 1
|
2320 |
IV 37%
Δ -0.68
θ -2.7
ν 1
|
|
IV 38%
Δ 0.27
θ -2.9
ν 1
|
2340 |
IV 38%
Δ -0.73
θ -2.5
ν 1
|
|
IV 39%
Δ 0.22
θ -2.7
ν 1
|
2360 MP |
IV 39%
Δ -0.78
θ -2.3
ν 1
|
|
IV 40%
Δ 0.19
θ -2.4
ν 1
|
2380 |
IV 40%
Δ -0.81
θ -2.0
ν 1
|
|
IV 41%
Δ 0.15
θ -2.2
ν 1
|
2400 |
IV 41%
Δ -0.85
θ -1.8
ν 1
|
|
IV 41%
Δ 0.13
θ -1.9
ν 1
|
2420 |
IV 41%
Δ -0.87
θ -1.5
ν 1
|
|
IV 42%
Δ 0.10
θ -1.7
ν 1
|
2440 |
IV 42%
Δ -0.90
θ -1.3
ν 1
|
|
IV 44%
Δ 0.09
θ -1.6
ν 0
|
2460 |
IV 44%
Δ -0.91
θ -1.1
ν 0
|
Chain Interpretation
Strategy Builder multi-leg payoff for MANKIND options · 2026-10-27 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
MANKIND — frequently asked questions
What is the Mankind Pharma Ltd. share price today?
MANKIND is trading at ₹2,253.20 (+0.00% vs previous close), per the latest update on this page.
What is the P/E ratio of Mankind Pharma Ltd.?
MANKIND (Mankind Pharma Ltd.) has a trailing twelve-month P/E ratio of 45.6.
What is the market cap of Mankind Pharma Ltd.?
MANKIND has a market capitalisation of approximately ₹93,067 crore.
Is MANKIND near its 52-week high?
MANKIND is trading -14.7% from its 52-week high of ₹2,642.00 as of 2026-10-19.
What is the RSI of MANKIND?
The 14-day RSI of MANKIND is 35.3, which is considered neutral.
Is MANKIND above its 200-day moving average?
MANKIND is trading below its 200-DMA of ₹2,311.64 (-2.5% away).
What is the F&O buildup in MANKIND?
The latest end-of-day derivatives data classifies MANKIND as Short Buildup (bias: bearish), based on the day's combined price and open-interest change.
What is the max pain and PCR for MANKIND options?
MANKIND's option-chain max pain strike is ₹2,360 and its put-call ratio (OI) is 0.47, from the latest end-of-day option chain.
Are FIIs or big investors buying MANKIND?
Strota tracks every bulk and block deal in MANKIND with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.
What is the latest broker call on MANKIND?
The most recent analyst call reported in the press is InCred: Initiate (2026-08-20). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.